Walleye Trading LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $280,572 - $344,412	1,200 Added 30.0%	5,200 $1.43 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $11.2 Million - $19.4 Million	-78,500 Reduced 95.15%	4,000 $972,000
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $1.99 Million - $2.7 Million	-13,600 Reduced 14.15%	82,500 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $11.9 Million - $15.5 Million	78,700 Added 452.3%	96,100 $18.4 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $973,389 - $1.21 Million	-5,700 Reduced 24.68%	17,400 $3.08 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $832,545 - $954,225	-4,500 Reduced 16.3%	23,100 $4.39 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $2.54 Million - $3.27 Million	-13,900 Reduced 33.49%	27,600 $5.53 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $12.8 Million - $16.6 Million	-68,800 Reduced 62.38%	41,500 $9.86 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $5.07 Million - $8.49 Million	36,600 Added 49.66%	110,300 $22.1 Million
Q2 2022 Aug 08, 2022	BUY	$120.42 - $169.29 $6.94 Million - $9.75 Million	57,600 Added 357.76%	73,700 $10.7 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $826,670 - $1.13 Million	6,500 Added 67.71%	16,100 $2.63 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $670,152 - $879,018	4,200 Added 77.78%	9,600 $1.63 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $4.16 Million - $5.09 Million	-24,500 Reduced 81.94%	5,400 $1.02 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $3.59 Million - $4.94 Million	27,900 Added 1395.0%	29,900 $5.07 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $2.35 Million - $3.25 Million	-18,500 Reduced 90.24%	2,000 $282,000
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $145,428 - $198,588	-1,200 Reduced 5.53%	20,500 $2.99 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $1.8 Million - $2.71 Million	-17,300 Reduced 44.36%	21,700 $3.21 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $977,760 - $1.41 Million	10,500 Added 36.84%	39,000 $4.25 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $1.65 Million - $2.75 Million	22,100 Added 345.31%	28,500 $3.28 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $794,080 - $983,583	-11,200 Reduced 63.64%	6,400 $515,000
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $777,148 - $1.09 Million	11,800 Added 203.45%	17,600 $1.28 Million
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $50,932 - $65,415	-700 Reduced 10.77%	5,800 $542,000
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $275,748 - $388,652	4,400 Added 209.52%	6,500 $474,000
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $376,336 - $527,481	-4,300 Reduced 67.19%	2,100 $184,000
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $565,184 - $689,920	6,400 New	6,400 $630,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.16 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.18 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.4 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.32 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.25 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account